Compare PRPO & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRPO | KG |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Property-Casualty Insurers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 33.0M |
| IPO Year | 2000 | 2025 |
| Metric | PRPO | KG |
|---|---|---|
| Price | $18.95 | $4.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.1K | 10.9K |
| Earning Date | 11-10-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 92.15 | ★ 1819.15 |
| EPS | ★ N/A | N/A |
| Revenue | $24,049,000.00 | ★ $34,049,000.00 |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 29.77 | ★ 785.08 |
| 52 Week Low | $17.79 | $3.84 |
| 52 Week High | $33.63 | $18.56 |
| Indicator | PRPO | KG |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 41.53 |
| Support Level | N/A | $3.84 |
| Resistance Level | $24.78 | $5.54 |
| Average True Range (ATR) | 1.09 | 0.37 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 24.44 | 29.61 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.